skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: Base de dados/Biblioteca: EZB Electronic Journals Library remover Base de dados/Biblioteca: Journals@Ovid Complete remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Thymbra capitata essential oil has a significant antimicrobial activity against methicillin‐resistant Staphylococcus aureus pre‐formed biofilms
Thymbra capitata essential oil has a significant antimicrobial activity against methicillin‐resistant Staphylococcus aureus pre‐formed biofilms
Material Type:
Artigo 		Adicionar ao Meu Espaço

Thymbra capitata essential oil has a significant antimicrobial activity against methicillin‐resistant Staphylococcus aureus pre‐formed biofilms

Almeida, L. ; Lopes, N. ; Gaio, V. ; Cavaleiro, C. ; Salgueiro, L. ; Silva, V. ; Poeta, P. ; Cerca, N.

Letters in applied microbiology, 2022-05, Vol.74 (5), p.787-795 [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
2
Endogenous GAB AA receptor activity suppresses glioma growth
Endogenous GAB AA receptor activity suppresses glioma growth
Material Type:
Artigo 		Adicionar ao Meu Espaço

Endogenous GAB AA receptor activity suppresses glioma growth

Blanchart, A ; Fernando, R ; Häring, M ; Assaife-Lopes, N ; Romanov, R A ; Andäng, M ; Harkany, T ; Ernfors, P

Oncogene, 2017-02, Vol.36 (6), p.777 [Periódico revisado por pares]

England

Texto completo disponível

Citações Citado por
3
Brazil oil spill response: Protect rhodolith beds
Brazil oil spill response: Protect rhodolith beds
Material Type:
Artigo 		Adicionar ao Meu Espaço

Brazil oil spill response: Protect rhodolith beds

Nasri Sissini, M ; Berchez, F ; Hall-Spencer, J ; Ghilardi-Lopes, N ; Carvalho, V F ; Schubert, N ; Koerich, G ; Diaz-Pulido, G ; Silva, J ; Serrão, E ; Assis, J ; Santos, R ; Floeter, S R ; Rörig, L ; Barufi, J B ; Bernardino, A F ; Francini-Filho, R ; Turra, A ; Hofmann, L C ; Aguirre, J ; Le Gall, L ; Peña, V ; Nash, M C ; Rossi, S ; Soares, M ; Pereira-Filho, G ; Tâmega, F ; Horta, P A Sills, Jennifer

Science (American Association for the Advancement of Science), 2020-01, Vol.367 (6474), p.156-156 [Periódico revisado por pares]

United States: American Association for the Advancement of Science (AAAS)

Texto completo disponível

Citações Citado por
4
Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial
Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcome of Patients With an Ultralow-Risk 70-Gene Signature in the MINDACT Trial

Lopes Cardozo, Josephine M N ; Drukker, Caroline A ; Rutgers, Emiel J T ; Schmidt, Marjanka K ; Glas, Annuska M ; Witteveen, Anke ; Cardoso, Fatima ; Piccart, Martine ; Esserman, Laura J ; Poncet, Coralie ; van 't Veer, Laura J

Journal of clinical oncology, 2022-04, Vol.40 (12), p.1335-1345 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
North and South Hemispheric Solar Activity for Cycles 21 – 23: Asymmetry and Conditional Volatility of Plage Region Areas
North and South Hemispheric Solar Activity for Cycles 21 – 23: Asymmetry and Conditional Volatility of Plage Region Areas
Material Type:
Artigo 		Adicionar ao Meu Espaço

North and South Hemispheric Solar Activity for Cycles 21 – 23: Asymmetry and Conditional Volatility of Plage Region Areas

Gonçalves, E. ; Mendes-Lopes, N. ; Dorotovič, I. ; Fernandes, J. M. ; Garcia, A.

Solar physics, 2014-06, Vol.289 (6), p.2283-2296 [Periódico revisado por pares]

Dordrecht: Springer Netherlands

Texto completo disponível

Citações Citado por
6
Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial
Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Outcome without any adjuvant systemic treatment in stage I ER+/HER2− breast cancer patients included in the MINDACT trial

Lopes Cardozo, J.M.N. ; Byng, D. ; Drukker, C.A. ; Schmidt, M.K. ; Binuya, M.A. ; van ’t Veer, L.J. ; Cardoso, F. ; Piccart, M. ; Smorenburg, C.H. ; Poncet, C. ; Rutgers, E.J.T.

Annals of oncology, 2022-03, Vol.33 (3), p.310-320 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
Budget Impact of Introducing Secukinumab In The Treatment of Moderate-To-Severe Plaque Psoriasis From The Private Payer Perspective In Brazil
Budget Impact of Introducing Secukinumab In The Treatment of Moderate-To-Severe Plaque Psoriasis From The Private Payer Perspective In Brazil
Material Type:
Artigo 		Adicionar ao Meu Espaço

Budget Impact of Introducing Secukinumab In The Treatment of Moderate-To-Severe Plaque Psoriasis From The Private Payer Perspective In Brazil

Suzuki, C ; Lopes, N

Value in health, 2017-10, Vol.20 (9), p.A891 [Periódico revisado por pares]

Lawrenceville: Elsevier Science Ltd

Texto completo disponível

Citações Citado por
8
PSY11 - Budget Impact of Introducing Secukinumab In The Treatment of Moderate-To-Severe Plaque Psoriasis From The Private Payer Perspective In Brazil
PSY11 - Budget Impact of Introducing Secukinumab In The Treatment of Moderate-To-Severe Plaque Psoriasis From The Private Payer Perspective In Brazil
Material Type:
Artigo 		Adicionar ao Meu Espaço

PSY11 - Budget Impact of Introducing Secukinumab In The Treatment of Moderate-To-Severe Plaque Psoriasis From The Private Payer Perspective In Brazil

Suzuki, C ; Lopes, N

Value in health, 2017-10, Vol.20 (9), p.A891-A891 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
9
PRS5 - Estimating the Financial Impact of Introducing Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) From the Perspective of Public Payer of São Paulo (Sp) – Brazil
PRS5 - Estimating the Financial Impact of Introducing Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) From the Perspective of Public Payer of São Paulo (Sp) – Brazil
Material Type:
Artigo 		Adicionar ao Meu Espaço

PRS5 - Estimating the Financial Impact of Introducing Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) From the Perspective of Public Payer of São Paulo (Sp) – Brazil

Suzuki, C ; Lopes, N

Value in health, 2017-10, Vol.20 (9), p.A888-A888 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
10
Estimating the Financial Impact of Introducing Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) From the Perspective of Public Payer of São Paulo (Sp) – Brazil
Estimating the Financial Impact of Introducing Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) From the Perspective of Public Payer of São Paulo (Sp) – Brazil
Material Type:
Artigo 		Adicionar ao Meu Espaço

Estimating the Financial Impact of Introducing Glycopyrronium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease (Copd) From the Perspective of Public Payer of São Paulo (Sp) – Brazil

Suzuki, C ; Lopes, N

Value in health, 2017-10, Vol.20 (9), p.A888 [Periódico revisado por pares]

Lawrenceville: Elsevier Science Ltd

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (670)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (677)
  2. Reports  (1)
  3. Anais de Congresso  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1992  (12)
  2. 1992Até1999  (45)
  3. 2000Até2007  (84)
  4. 2008Até2016  (200)
  5. Após 2016  (339)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (678)
  2. Japonês  (62)
  3. Espanhol  (3)
  4. Português  (2)
  5. Norueguês  (2)
  6. Alemão  (1)
  7. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.